Skip to main navigation
Skip to search
Skip to main content
Sort by
Neuroscience
Anti-Seizure Medication
10%
Anticonvulsant
22%
Antiseizure Medication
10%
Antithrombotic
9%
Atrial Fibrillation
20%
Brain Disease
6%
Brain Imaging
24%
Brain Ischemia
66%
Cerebral Hemorrhage
23%
Cerebral Venous Sinus Thrombosis
9%
Cerebrovascular Accident
100%
Cerebrovascular Disease
9%
Comorbidity
6%
Drug Therapy
12%
Duragesic
9%
Electroencephalogram
21%
Fentanyl
9%
Glycosylated Hemoglobin
18%
Hemoglobin A1c
18%
Hypoxic Ischemic Encephalopathy
6%
Ictal
43%
Interferon
9%
Ischemic Heart Disease
5%
Meditation
6%
Non-Rapid Eye Movement Sleep
11%
Psychogenic Non-Epileptic Seizure
18%
Relapsing Remitting Multiple Sclerosis
9%
Risk Factor
63%
Seizure Types
8%
Single-Photon Emission Computed Tomography
9%
Status Epilepticus
15%
Thrombectomy
8%
Thromboplastin
5%
Tonic-Clonic Seizure
20%
Warfarin
6%
Medicine and Dentistry
Anticoagulation
18%
Antithrombotic
18%
Apoplexy
46%
Aseptic Meningitis
9%
Blood Transfusion
9%
Brain Disease
9%
Brain Imaging
18%
Burst Suppression
6%
Cerebral Hemorrhage
6%
Cerebrovascular Disease
6%
Clinical Imaging
18%
Comorbidity
7%
Epileptic Seizure
53%
Factor A
9%
Intensive Care Unit
6%
Medical Record
9%
Observational Study
18%
Odds Ratio
9%
Outpatient
6%
Polytrauma
9%
Predictive Factor
9%
Prevalence
38%
Psychogenic Non-Epileptic Seizure
18%
Reperfusion Therapy
11%
Tertiary Care
9%
Tonic-Clonic Seizure
6%
Treatment Option
9%
Treatment Response
9%
Vitritis
9%
Vogt Koyanagi Syndrome
9%
Warfarin
6%
Pharmacology, Toxicology and Pharmaceutical Science
Adverse Event
8%
Anticoagulant Agent
27%
Atrial Fibrillation
9%
Brain Hemorrhage
11%
Brain Ischemia
9%
Cerebral Sinus Thrombosis
18%
Cerebrovascular Accident
31%
Factor A
18%
Health Status
6%
Infarction
6%
Multiple Sclerosis
18%
Observational Study
24%
Prevalence
42%
Thromboplastin
5%
Warfarin
7%